initiate

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:23 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

PairedWorld Foundation Unveils Innovative Solution to Digital Addiction and Loneliness during World Economic Forum and Announces Key Additions to Its Board and Strategic Partnerships

Source Node:
Time Stamp: January 29, 2024 6:28 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

Davos, Switzerland – As the World Economic Forum Annual Meeting 2024 has come to an end, a critical theme has resonated throughout the discussions: the deep and complex relationship between technology and modern society. Key topics, such as the escalating issues of digital addiction, loneliness, and isolation, sparked intense debates. Initiatives like Human Change, along with dialogues among the world's tech leaders about technology's potential to enhance humanity, have set the stage. Leading this charge, the PairedWorld Foundation unveiled its innovative approach, marking a significant milestone in harnessing emerging technology

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Crypto Valley Association Joins Hands with The Crypto Oasis to Boost Blockchain Development in the Middle East

Source Node:
Time Stamp: September 8, 2022 4:48 AM - Modified On: September 8, 2022 - Published By:
Source Cluster:
Republished By Plato

Key Highlights: Swiss-based Crypto Valley Association partners with Crypto Oasis and opens a chapter in Dubai to connect with the blockchain space in the Middle East.This initiative will improve collaboration for further growth and innovation in both regions.Faisal Zaidi, Co-Founder of the Crypto Oasis will be the Chapter Lead for the Middle East. Dubai, September 08 2022: Crypto Valley Association, the Switzerland-based association of blockchain corporates and crypto professionals, has partnered with Crypto Oasis, Dubai to connect the growing blockchain communities in both Switzerland and the Middle East. Sharing several